(Q35188653)

7 August 2017

Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers (English)

1 reference

7 August 2017

1 reference

9

Carl Grunfeld

1 reference

7 August 2017

Steven A Taylor

1

1 reference

7 August 2017

Grace A Lee

2

1 reference

7 August 2017

Vivian Y Pao

3

1 reference

7 August 2017

Jayaranjan Anthonypillai

4

1 reference

7 August 2017

Francesca T Aweeka

5

1 reference

7 August 2017

Jean-Marc Schwarz

6

1 reference

7 August 2017

Kathleen Mulligan

7

1 reference

7 August 2017

Morris Schambelan

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Journal of Acquired Immune Deficiency Syndromes

7 August 2017

1 reference

7 August 2017

55

1 reference

7 August 2017

3

1 reference

7 August 2017

361-364

1 reference

Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

The metabolic effects of lopinavir/ritonavir in HIV-negative men

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Insulin resistance in HIV protease inhibitor-associated diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Glucose clamp technique: a method for quantifying insulin secretion and resistance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Lack of effect of gastric acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir in HIV-infected patients.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Metabolic effects of indinavir in healthy HIV-seronegative men

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164483

Protease inhibitor-associated hyperglycaemia

27 September 2018

1 reference

12 December 2020

Severe diabetes associated with protease inhibitor therapy

1 reference

12 December 2020

Exacerbated Hyperglycemia Associated with Nelfinavir

1 reference

12 December 2020

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

1 reference

12 December 2020

Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen

1 reference

12 December 2020

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically

1 reference

12 December 2020

10.1097/QAI.0B013E3181E6A7D9

Identifiers

DOI

1 reference

release_x7ug6bqmzvgo5owextwxti3vtu

7 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x7ug6bqmzvgo5owextwxti3vtu

24 November 2022

mapped directly with Wikidata item

PMCID

3164483

1 reference

7 August 2017

1 reference